Marta Torres-Narbona

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

Jesús Guinea, Marta Torres-Narbona, Paloma Gijón et al. · Clinical Microbiology and Infection · 2009 · 396 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16

In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, <i>Candida</i> , <i>Aspergillus</i> , <i>Fusarium</i> , and <i>Scedosporium</i> Species

Jesús Guinea, Teresa Peláez, Sandra Recio et al. · Antimicrobial Agents and Chemotherapy · 2008 · 213 citations · Full text

Life Sciences, Microbiology, Pharmacotherapy +17

Impact of Zygomycosis on Microbiology Workload: a Survey Study in Spain

Marta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón et al. · Journal of Clinical Microbiology · 2007 · 118 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest

Marta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón et al. · Antimicrobial Agents and Chemotherapy · 2006 · 66 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

Mariana G. López, Álvaro Chiner‐Oms, Darı́o Garcı́a de Viedma et al. · Nature Genetics · 2021 · 58 citations · Full text

Veterinary Medicine, Genetics, Infectious Diseases +17